Group structure
11 companies in 7 countries
Loading your page…
Loading your page…
11 companies in 7 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 82
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACYCLOVIR200mg · Capsule | Aciclovir | United States | Marketed | 1996 |
| ALLAY500mg; 5mg · Capsule | Paracetamol, Hydrocodone | United States | Not marketed | 1989 |
| C-SOLVE-22% · Swab | Erythromycin | United States | Not marketed | 1993 |
| CABERGOLINE0.5mg · Tablet | Cabergoline | United States | Marketed | 2005 |
| CEPHRADINE250mg | 500mg · Capsule | Cephradine | United States | Not marketed | 1987 |
| CHLORAMPHENICOL250mg · Capsule | Chloramphenicol | United States | Not marketed | 1980 |
| CHLORPROMAZINE HYDROCHLORIDE100MG | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 10MG | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 200MG | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | · Tablet | Chlorpromazine | United States | Marketed | 1972 |
| CYCLOSPORINE100mg/ml · Solution | Ciclosporin | United States | Marketed | 2000 |
| DISOPYRAMIDE PHOSPHATE100mg base | 150mg base · Capsule | Disopyramide | United States | Marketed | 1985 |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE10mg; 25mg | 5mg; 12.5mg · Tablet | Enalapril, Hydrochlorothiazide | United States | Marketed | 2001 |
| ERYTHROMYCIN ESTOLATE125mg base | 250mg base · Capsule | Erythromycin | United States | Not marketed | 1979 |
| FLURBIPROFEN100mg | 50mg · Tablet | Flurbiprofen | United States | Marketed | 1994 |
| FLUTEX0.025% | 0.1% | 0.5% · Cream | Triamcinolone | United States | Not marketed | 1978 |
| FLUTEX0.025% | 0.1% | 0.5% · Ointment | Triamcinolone | United States | Not marketed | 1988 |
| HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE25mg; 15mg; 0.1mg · Tablet | Hydralazine, Hydrochlorothiazide, Reserpine | United States | Not marketed | 1975 |
| HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50100mg; 50mg · Capsule | Hydralazine, Hydrochlorothiazide | United States | Not marketed | 1984 |
| HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 25/2525mg; 25mg · Capsule | Hydralazine, Hydrochlorothiazide | United States | Not marketed | 1984 |
| HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 50/5050mg; 50mg · Capsule | Hydralazine, Hydrochlorothiazide | United States | Not marketed | 1984 |
| HYDROGENATED ERGOT ALKALOIDS0.5mg | 1mg · Tablet | Ergoloid mesylates | United States | Not marketed | 1980 |
| HYDROSERPINE PLUS (R-H-H)25mg; 15mg; 0.1mg · Tablet | Hydralazine, Hydrochlorothiazide, Reserpine | United States | Not marketed | 1975 |
| NASALIDE0.025MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, metered | Flunisolide | United States | Not marketed | 1981 |
| NOGENIC HC1% · Cream | Hydrocortisone | United States | Not marketed | 1988 |
| OXAZEPAM10mg | 15mg | 30mg · Capsule | Oxazepam | United States | Marketed | 1987 |
| PHENTERMINE HYDROCHLORIDE30mg | 37.5mg | 8mg · Tablet | Phentermine | United States | Marketed | 1976 |
| PROBENECID500mg · Tablet | Probenecid | United States | Marketed | 1976 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 37 | 0 | 37 | CompaniesAll medicines |
| United States | 34 | 34 | 0 | CompaniesAll medicines |
| Saudi Arabia | 11 | 11 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.